What does Relay Therapeutics, Inc. do?
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and…
What is Relay Therapeutics, Inc.'s P/E and P/B ratio?
Relay Therapeutics, Inc. has a P/E ratio of -11.8 and a P/B ratio of 4.52.
What is Relay Therapeutics, Inc.'s debt-to-equity ratio?
Relay Therapeutics, Inc. has a debt-to-equity ratio of 0.03.
How much does Relay Therapeutics, Inc. owe compared with what it owns?
Relay Therapeutics, Inc. owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Relay Therapeutics, Inc.'s Positivity rank?
Relay Therapeutics, Inc. is ranked #5,434 of 6,775 companies globally and #2,947 of 4,000 in United States on PositoAI, with a Positivity Score of 17,448.
Does Relay Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Relay Therapeutics, Inc..
Where can I read the latest news about Relay Therapeutics, Inc.?
Recent headlines about Relay Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Relay Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Relay Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.